Avricore Health Past Earnings Performance

Past criteria checks 0/6

Avricore Health has been growing earnings at an average annual rate of 28.3%, while the Healthcare Services industry saw earnings growing at 20% annually. Revenues have been growing at an average rate of 69.2% per year.

Key information

28.33%

Earnings growth rate

42.55%

EPS growth rate

Healthcare Services Industry Growth1.72%
Revenue growth rate69.23%
Return on equity-34.00%
Net Margin-13.98%
Last Earnings Update31 Dec 2024

Recent past performance updates

No updates

Recent updates

Revenue & Expenses Breakdown

How Avricore Health makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:AVCR.F Revenue, expenses and earnings (CAD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 245-120
30 Sep 245020
30 Jun 244020
31 Mar 244020
31 Dec 233-120
30 Sep 233-120
30 Jun 233-120
31 Mar 232-110
31 Dec 222-110
30 Sep 221-110
30 Jun 220-110
31 Mar 220-110
31 Dec 210-210
30 Sep 210-220
30 Jun 210-210
31 Mar 210-210
31 Dec 200-110
30 Sep 200-110
30 Jun 200-110
31 Mar 200-210
31 Dec 190-210
30 Sep 190-320
30 Jun 190-320
31 Mar 190-320
31 Dec 180-320
30 Sep 180-320
30 Jun 181-320
31 Mar 181-320
31 Dec 171-320
30 Sep 170-320
30 Jun 171-220
31 Mar 171-320
31 Dec 161-320
30 Sep 161-220
30 Jun 161-230
31 Mar 161-330
31 Dec 150-320
30 Sep 150-320
30 Jun 150-220
31 Mar 150-110
31 Dec 140-110
30 Sep 140-110

Quality Earnings: AVCR.F is currently unprofitable.

Growing Profit Margin: AVCR.F is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: AVCR.F is unprofitable, but has reduced losses over the past 5 years at a rate of 28.3% per year.

Accelerating Growth: Unable to compare AVCR.F's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: AVCR.F is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (7.3%).


Return on Equity

High ROE: AVCR.F has a negative Return on Equity (-34%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/30 09:25
End of Day Share Price 2025/05/28 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Avricore Health Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.